Literature DB >> 2320567

Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy.

T A Slotkin1, F J Seidler, B J Crain, J M Bell, G Bissette, C B Nemeroff.   

Abstract

Brain regions from patients with or without Alzheimer disease (AD) were obtained within 2 hr of death and examined for indices of presynaptic cholinergic function. Consistent with loss of cholinergic projections, cerebral cortical areas involved in AD exhibited decreased choline acetyltransferase (acetyl-CoA:choline O-acetyltransferase, EC 2.3.1.6) activity. However, remaining nerve terminals in these regions displayed marked up-regulation of synaptosomal high affinity [3H]choline uptake, a result indicative of relative cholinergic hyperactivity. As choline uptake is also rate-limiting in acetylcholine biosynthesis, these findings have implications for both therapy and identification of causes contributing to neuronal death in AD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320567      PMCID: PMC53707          DOI: 10.1073/pnas.87.7.2452

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine.

Authors:  J R Simon; S Atweh; M J Kuhar
Journal:  J Neurochem       Date:  1976-05       Impact factor: 5.372

2.  Post-mortem changes in high affinity choline uptake.

Authors:  N Klemm; M J Kuhar
Journal:  J Neurochem       Date:  1979-05       Impact factor: 5.372

3.  Cellular localization of messenger RNA encoding amyloid-beta-protein in normal tissue and in Alzheimer disease.

Authors:  D E Schmechel; D Goldgaber; D S Burkhart; J R Gilbert; D C Gajdusek; A D Roses
Journal:  Alzheimer Dis Assoc Disord       Date:  1988       Impact factor: 2.703

4.  Presynaptic cholinergic dysfunction in patients with dementia.

Authors:  N R Sims; D M Bowen; S J Allen; C C Smith; D Neary; D J Thomas; A N Davison
Journal:  J Neurochem       Date:  1983-02       Impact factor: 5.372

5.  High affinity choline uptake in striatum and hippocampus: differential effects of treatments which release acetylcholine.

Authors:  K A Sherman; M J Zigmond; I Hanin
Journal:  Life Sci       Date:  1978-10-30       Impact factor: 5.037

6.  A post-mortem study of the cholinergic and GABA systems in senile dementia.

Authors:  M N Rossor; N J Garrett; A L Johnson; C Q Mountjoy; M Roth; L L Iversen
Journal:  Brain       Date:  1982-06       Impact factor: 13.501

7.  Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.

Authors:  R J Rylett; M J Ball; E H Colhoun
Journal:  Brain Res       Date:  1983-12-19       Impact factor: 3.252

8.  Ontogeny of (--)-[3H]norepinephrine uptake properties of synaptic storage vesicles of rat brain.

Authors:  D F Kirksey; F J Seidler; T A Slotkin
Journal:  Brain Res       Date:  1978-07-14       Impact factor: 3.252

9.  Development of high affinity choline uptake and associated acetylcholine synthesis in the rat fascia dentata.

Authors:  D L Shelton; J V Nadler; C W Cotman
Journal:  Brain Res       Date:  1979-03-16       Impact factor: 3.252

10.  Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.

Authors:  D M Bowen; S J Allen; J S Benton; M J Goodhardt; E A Haan; A M Palmer; N R Sims; C C Smith; J A Spillane; M M Esiri; D Neary; J S Snowdon; G K Wilcock; A N Davison
Journal:  J Neurochem       Date:  1983-07       Impact factor: 5.372

View more
  19 in total

1.  The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease.

Authors:  G Ehrenstein; Z Galdzicki; G D Lange
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

Review 2.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Ultrastructural localization of high-affinity choline transporter in the rat anteroventral thalamus and ventral tegmental area: differences in axon morphology and transporter distribution.

Authors:  Ericka C Holmstrand; Josephine Asafu-Adjei; Allan R Sampson; Randy D Blakely; Susan R Sesack
Journal:  J Comp Neurol       Date:  2010-06-01       Impact factor: 3.215

Review 4.  The Promises and Challenges of Erythropoietin for Treatment of Alzheimer's Disease.

Authors:  Jiahong Sun; Jan Michelle Martin; Victoria Vanderpoel; Rachita K Sumbria
Journal:  Neuromolecular Med       Date:  2019-01-17       Impact factor: 3.843

5.  Amyloid beta peptide 1-40 and the function of rat hippocampal hemicholinium-3 sensitive choline carriers: effects of a proteolytic degradation in vitro.

Authors:  Z Kristofiková; H Tejkalová; J Klaschka
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

6.  Effect of cholinergic signaling on neuronal cell bioenergetics.

Authors:  Jianghua Lu; Lezi E; Nairita Roy; Lewis Hutfles; Eva Selfridge; Eric Funk; Jeffrey M Burns; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 7.  Alzheimer's Disease Therapeutic Approaches.

Authors:  Maria Revi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 8.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody.

Authors:  Kelly R Bales; Eleni T Tzavara; Su Wu; Mark R Wade; Frank P Bymaster; Steven M Paul; George G Nomikos
Journal:  J Clin Invest       Date:  2006-02-23       Impact factor: 14.808

10.  Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.

Authors:  T A Slotkin; C B Nemeroff; G Bissette; F J Seidler
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.